Record Information |
---|
Version | 1.0 |
---|
Creation Date | 2016-05-22 07:29:03 UTC |
---|
Update Date | 2016-11-09 01:16:17 UTC |
---|
Accession Number | CHEM020837 |
---|
Identification |
---|
Common Name | Indomethacin farnesil |
---|
Class | Small Molecule |
---|
Description | Indometacin farnesil (INN) is a prodrug of the nonsteroidal anti-inflammatory drug (NSAID) indometacin, designed to reduce the occurrence of side-effects by esterification of the carboxyl group on indometacin with farnesol. Indometacin farnesil was first approved in Japan in 1991, and is available in Japan and Indonesia, under the trade names Infree and Dialon, respectively. |
---|
Contaminant Sources | - ToxCast & Tox21 Chemicals
|
---|
Contaminant Type | Not Available |
---|
Chemical Structure | |
---|
Synonyms | Value | Source |
---|
Infree | Kegg | Indometacin farnesil | MeSH | [(2E,6E)-3,7,11-Trimethyldodeca-2,6,10-trienyl] 2-[1-(4-chlorobenzoyl)-5-methoxy-2-methylindol-3-yl]acetic acid | Generator | Indomethacin farnesil | MeSH | (2E,6E)-3,7,11-Trimethyldodeca-2,6,10-trien-1-yl 2-[1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl]acetic acid | Generator |
|
---|
Chemical Formula | C34H40ClNO4 |
---|
Average Molecular Mass | 562.150 g/mol |
---|
Monoisotopic Mass | 561.265 g/mol |
---|
CAS Registry Number | 85801-02-1 |
---|
IUPAC Name | (2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-yl 2-[1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl]acetate |
---|
Traditional Name | infree |
---|
SMILES | [H]\C(CC\C(C)=C(/[H])COC(=O)CC1=C(C)N(C(=O)C2=CC=C(Cl)C=C2)C2=C1C=C(OC)C=C2)=C(\C)CCC=C(C)C |
---|
InChI Identifier | InChI=1S/C34H40ClNO4/c1-23(2)9-7-10-24(3)11-8-12-25(4)19-20-40-33(37)22-30-26(5)36(32-18-17-29(39-6)21-31(30)32)34(38)27-13-15-28(35)16-14-27/h9,11,13-19,21H,7-8,10,12,20,22H2,1-6H3/b24-11+,25-19+ |
---|
InChI Key | CFIGYZZVJNJVDQ-LMJOQDENSA-N |
---|
Chemical Taxonomy |
---|
Description | belongs to the class of organic compounds known as benzoylindoles. These are organic compounds containing an indole attached to a benzoyl moiety through the acyl group. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organoheterocyclic compounds |
---|
Class | Indoles and derivatives |
---|
Sub Class | Benzoylindoles |
---|
Direct Parent | Benzoylindoles |
---|
Alternative Parents | |
---|
Substituents | - Benzoylindole
- Sesquiterpenoid
- Farsesane sesquiterpenoid
- Indole-3-acetic acid derivative
- Indolyl carboxylic acid derivative
- Indolecarboxylic acid derivative
- 4-halobenzoic acid or derivatives
- Halobenzoic acid or derivatives
- 3-alkylindole
- Indole
- Benzoic acid or derivatives
- Benzoyl
- Anisole
- Halobenzene
- Alkyl aryl ether
- Chlorobenzene
- Substituted pyrrole
- Monocyclic benzene moiety
- Aryl halide
- Aryl chloride
- Benzenoid
- Heteroaromatic compound
- Pyrrole
- Carboxylic acid ester
- Azacycle
- Carboxylic acid derivative
- Ether
- Monocarboxylic acid or derivatives
- Organic oxygen compound
- Carbonyl group
- Organonitrogen compound
- Organooxygen compound
- Organic nitrogen compound
- Hydrocarbon derivative
- Organic oxide
- Organochloride
- Organohalogen compound
- Organopnictogen compound
- Aromatic heteropolycyclic compound
|
---|
Molecular Framework | Aromatic heteropolycyclic compounds |
---|
External Descriptors | Not Available |
---|
Biological Properties |
---|
Status | Detected and Not Quantified |
---|
Origin | Not Available |
---|
Cellular Locations | Not Available |
---|
Biofluid Locations | Not Available |
---|
Tissue Locations | Not Available |
---|
Pathways | Not Available |
---|
Applications | Not Available |
---|
Biological Roles | Not Available |
---|
Chemical Roles | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Appearance | Not Available |
---|
Experimental Properties | Property | Value |
---|
Melting Point | Not Available | Boiling Point | Not Available | Solubility | Not Available |
|
---|
Predicted Properties | |
---|
Spectra |
---|
Spectra | Spectrum Type | Description | Splash Key | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 10V, Positive | splash10-03dl-0445090000-c8669287f99cbefc1bab | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 20V, Positive | splash10-0a4l-4957000000-1ca221c59239c5360a6a | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 40V, Positive | splash10-03xr-8926000000-556cc9fe1e219a7ea9f0 | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 10V, Negative | splash10-03dr-0039070000-57889fc6cf51692f8ba6 | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 20V, Negative | splash10-0btl-0139010000-84c9ab98b11fc8ba35f6 | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 40V, Negative | splash10-000f-0569000000-284e8c4925a13caef0a2 | Spectrum |
|
---|
Toxicity Profile |
---|
Route of Exposure | Not Available |
---|
Mechanism of Toxicity | Not Available |
---|
Metabolism | Not Available |
---|
Toxicity Values | Not Available |
---|
Lethal Dose | Not Available |
---|
Carcinogenicity (IARC Classification) | Not Available |
---|
Uses/Sources | Not Available |
---|
Minimum Risk Level | Not Available |
---|
Health Effects | Not Available |
---|
Symptoms | Not Available |
---|
Treatment | Not Available |
---|
Concentrations |
---|
| Not Available |
---|
External Links |
---|
DrugBank ID | Not Available |
---|
HMDB ID | Not Available |
---|
FooDB ID | Not Available |
---|
Phenol Explorer ID | Not Available |
---|
KNApSAcK ID | Not Available |
---|
BiGG ID | Not Available |
---|
BioCyc ID | Not Available |
---|
METLIN ID | Not Available |
---|
PDB ID | Not Available |
---|
Wikipedia Link | Indometacin farnesil |
---|
Chemspider ID | Not Available |
---|
ChEBI ID | Not Available |
---|
PubChem Compound ID | 5282183 |
---|
Kegg Compound ID | Not Available |
---|
YMDB ID | Not Available |
---|
ECMDB ID | Not Available |
---|
References |
---|
Synthesis Reference | Not Available |
---|
MSDS | Not Available |
---|
General References | Not Available |
---|